Trialbee’s Smart Patient Matching drives 30% referral conversion rate
A large global pharma initiated a phase III study testing the efficacy of combining two existing drugs in overactive bladder patients.
Offered Free by: Trialbee AB
See All Resources from: Trialbee AB
Mapping clinical data to CDISC SDTM is mandatory for clinical trial submissions. But accurately mapping…
A high-level meeting between Uganda and Egypt to strengthen pharmaceutical cooperation CAIRO, Egypt (AfricaNewswire.Net) —…
اجتماع رفيع المستوى بين أوغندا ومصر لتعزيز التعاون الصيدلاني القاهرة، مصر، نوفمبر 2024 (AfricaNewswire.Net) في…